Monday, December 22, 2025
ADVT 
International

Trump issues letters, set to impose 25 pc tariffs on Japan, South Korea from Aug 1

Darpan News Desk The Canadian Press, 07 Jul, 2025 11:03 AM
  • Trump issues letters, set to impose 25 pc tariffs on Japan, South Korea from Aug 1

US President Donald Trump on Monday started sending out tariff letters to countries, saying he would impose a 25 per cent tariff on goods from Japan and South Korea from August 1. 

The US President announced the decision on his social media platform, Truth Social, where he posted copies of the letters.

The letters warned Japan and South Korea not to retaliate by increasing their own import taxes, or else the US administration would increase import taxes.

“If for any reason you decide to raise your tariffs, then, whatever the number you choose to raise them by, will be added onto the 25 per cent that we charge,” Trump said in the letters to Japanese Prime Minister Shigeru Ishiba and South Korean President Lee Jae-myung.

“Please understand that the 25 per cent number is far less than what is needed to eliminate the Trade Deficit disparity we have with your country,” Trump said in both letters, encouraging them to manufacture goods in the United States to avoid tariffs.

“There will be no tariff if South Korea or Japan or companies within your country, decide to build or manufacture product within the United States and, in fact, we will do everything possible to get approvals quickly, professionally, and routinely-In other words, in a matter of weeks,” Trump added.

Trump has threatened to send more letters out to heads of countries before the July 9 deadline, to make deals or face the threat of higher tariffs.

“These Tariffs may be modified, upward or downward, depending on our relationship with your country. You will never be disappointed with the United States of America,” Trump said in the letters sent out to Japan and South Korea.

Meanwhile, the United States' Treasury Secretary Scott Bessent said that Washington is close to reaching agreements on several trade deals as “a lot of proposals” have poured in from various countries at the last minute.

Trump has announced a number of trade deals, including with Vietnam and China. He had stated last month that the US and India “may sign an agreement that will open up India for US goods.

India’s high-level official delegation, led by chief negotiator Rajesh Agrawal, has returned from Washington after the trade talks with US officials without reaching a final agreement on the sensitive issue of trade in agricultural and dairy products that the US is pushing for.

Picture Courtesy: IANS 

MORE International ARTICLES

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

China permits Indian students to return on 'need-assessed' basis

China permits Indian students to return on 'need-assessed' basis
According to the Embassy, following the meeting of External Affairs Minister S. Jaishankar with his Chinese counterpart Wang Yi on March 25, the Chinese side has expressed its willingness to consider facilitating the return of Indian students to China on a need-assessed basis.

China permits Indian students to return on 'need-assessed' basis